Abstract
As the resident innate immune cells of the central nervous system (CNS), microglia fulfil a critical role in maintaining tissue homeostasis and in directing and eliciting molecular responses to CNS damage. The human disease Multiple Sclerosis and animal models of inflammatory demyelination are characterized by a complex interplay between degenerative and regenerative processes, many of which are regulated and mediated by microglia.Cellular communication between microglia and other neural and immune cells is controlled to a large extent by the activity of cytokines. Here we review the role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination, highlighting their importance in potentiating cell damage, promoting neuroprotection and enhancing cellular repair in a context-dependent manner.
| Original language | English |
|---|---|
| Pages (from-to) | 99-132 |
| Number of pages | 34 |
| Journal | NeuroMolecular Medicine |
| Volume | 12 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jun 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cytokines
- Experimental autoimmune encephalomyelitis (EAE)
- Inflammatory demyelination
- Innate immunity
- Interferons
- Interleukins
- Macrophages
- Microglia
- Multiple Sclerosis
- Myelin
- Oligodendrocyte
- Remyelination
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver